Antibiotics intended to treat infections elsewhere in the body can inadvertently kill off the "good" bacteria in the gut, making room for harmful bacteria, such as C. diff, to flourish. These toxins ...

One of the most common health-care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found. Clostridium difficile ...

Add Yahoo as a preferred source to see more of our stories on Google. Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a ...

A C. diff (Clostridioides difficile) diet may help alleviate diarrhea (the primary symptom) that is associated with this bacterial infection. Clostridioides difficile (previously known as Clostridium ...

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile - commonly known as C. diff - are a serious and persistent problem for patients and ...

Mayo Clinic has added robots in its fight against Clostridium difficile (C-diff) bacteria. In the U.S., C-diff is one of the most common infections patients can get while receiving care at a health ...

A new imaging approach used microscopic glowing tags to reveal gene activity in individual C. diff cells in gut tissue samples from infected mice. Here, a resulting image shows a round cross-section ...

There are about half a million C. diff infections every year in the United States. About 30,000 people die from them annually. But if you’ve had C. diff, you’re more likely to get it again. About 1 in ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

Clostridioides difficile (C. diff) infection (CDI) happens when the bacteria multiply rapidly in the gut, releasing toxins that damage the colon lining and cause diarrhea, abdominal pain, cramping, ...

A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in the U.S. annually. The bacterium is potentially ...